Statistics
Publications
3
Citations
283
H-Index
3
Active since
2004
Affiliations
Elisabeth Bertl is an author at German Cancer Research Center specializing in cancer pharmacology, oncology, and angiogenesis.
Publications per year
2004–2007
3
3
Tyrosine kinase inhibitor SU6668 represses chondrosarcoma growth via antiangiogenesis in vivo
Frank M. Klenke, Amir Abdollahi, Elisabeth Bertl et al. · BMC Cancer · 2007 · 59 citations · Full text
Medicine, Oncology, Pharmacology +16
1–3 of 3